Athlete’s Foot (tinea pedis) is a widespread disease. About 15% of the UK population1 have it at any one time, and for most sufferers, it’s a long-term problem. In a recent study of 900 sufferers in the UK, France and Germany, 65% said they had more than four incidences a year, and 66% said that they’d been periodic sufferers for four years or more, 23% have even suffered for more than 10 years.2
This professional section of this website is designed to help you diagnose, treat and explain Athlete’s Foot and introduces a newly-available treatment called Lamisil Once®.
| ||
The active ingredient of Lamisil AT® and Lamisil Once®, terbinafine hydrochloride, inhibits the enzyme squalene epoxidase, which is essential for the formation of ergosterol (a vital component of fungal cell membranes).
Lamisil Once® is a new product for the treatment of Athlete’s Foot. It combines the fungicidal action of terbinafine with a breakthrough delivery system – a film which delivers the active ingredient immediately and progressively from just one application. Clinical studies have shown it to be effective in treating athlete’s foot after a single application.
| ||
1 Evans EGV ‘The clinical efficacy of terbinafine in the treatment of fungal infections of the skin’, Rev Contemp Pharmacother 1997; 8:325-41.
2 Novartis Consumer Research, 2005: 900 respondents in the UK, France and Germany.
